Roufosse C - Search Results

1

Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome.

Willicombe M, Roufosse C, Brookes P, Galliford JW, McLean AG, Dorling A, Warrens AN, Cook TH, Cairns TD, Taube D. Willicombe M, et al. Among authors: roufosse c. Transplantation. 2011 Jul 27;92(2):176-82. doi: 10.1097/TP.0b013e318222c9c6. Transplantation. 2011. PMID: 21637139

2

DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy.

Lord GM, Hollstein M, Arlt VM, Roufosse C, Pusey CD, Cook T, Schmeiser HH. Lord GM, et al. Among authors: roufosse c. Am J Kidney Dis. 2004 Apr;43(4):e11-7. doi: 10.1053/j.ajkd.2003.11.024. Am J Kidney Dis. 2004. PMID: 15042566

3

Lupus podocytopathy.

Shea-Simonds P, Cairns TD, Roufosse C, Cook T, Vyse TJ. Shea-Simonds P, et al. Among authors: roufosse c. Rheumatology (Oxford). 2009 Dec;48(12):1616-8. doi: 10.1093/rheumatology/kep256. Epub 2009 Aug 27. Rheumatology (Oxford). 2009. PMID: 19713441 No abstract available.

4

Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy.

Willicombe M, Brookes P, Santos-Nunez E, Galliford J, Ballow A, Mclean A, Roufosse C, Cook HT, Dorling A, Warrens AN, Cairns T, Taube D. Willicombe M, et al. Among authors: roufosse c. Am J Transplant. 2011 Mar;11(3):470-7. doi: 10.1111/j.1600-6143.2010.03421.x. Epub 2011 Feb 7. Am J Transplant. 2011. PMID: 21299828 Free article.

5

Paraprotein 'zippers'.

Bravou V, McLean AG, Loucaidou M, Cairns TD, Cook HT, Roufosse CA. Bravou V, et al. Kidney Int. 2011 Jul;80(1):126. doi: 10.1038/ki.2011.54. Kidney Int. 2011. PMID: 21673739 Free article. No abstract available.

6

Kidney transplantation with minimized maintenance: alemtuzumab induction with tacrolimus monotherapy--an open label, randomized trial.

Chan K, Taube D, Roufosse C, Cook T, Brookes P, Goodall D, Galliford J, Cairns T, Dorling A, Duncan N, Hakim N, Palmer A, Papalois V, Warrens AN, Willicombe M, McLean AG. Chan K, et al. Among authors: roufosse c. Transplantation. 2011 Oct 15;92(7):774-80. doi: 10.1097/TP.0b013e31822ca7ca. Transplantation. 2011. PMID: 21836540 Clinical Trial.

7

Dissociation of ferritin and hepcidin in a case of adult-onset Still's disease.

Tharmalingam H, Ashby DR, Busbridge M, Roufosse C, Cairns TD. Tharmalingam H, et al. Among authors: roufosse c. Int J Hematol. 2011 Oct;94(4):408-409. doi: 10.1007/s12185-011-0926-4. Epub 2011 Sep 23. Int J Hematol. 2011. PMID: 21948263 No abstract available.

8

A case of chronic antibody-mediated rejection in the making.

Bravou V, Galliford J, McLean A, Willicombe M, Taube D, Cook HT, Roufosse C. Bravou V, et al. Among authors: roufosse c. Clin Nephrol. 2013 Oct;80(4):306-9. doi: 10.5414/CN107462. Clin Nephrol. 2013. PMID: 22579273

9

De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy.

Willicombe M, Brookes P, Sergeant R, Santos-Nunez E, Steggar C, Galliford J, McLean A, Cook TH, Cairns T, Roufosse C, Taube D. Willicombe M, et al. Among authors: roufosse c. Transplantation. 2012 Jul 27;94(2):172-7. doi: 10.1097/TP.0b013e3182543950. Transplantation. 2012. PMID: 22735711

10

Peritubular capillary basement membrane multilayering on electron microscopy: a useful marker of early chronic antibody-mediated damage.

Roufosse CA, Shore I, Moss J, Moran LB, Willicombe M, Galliford J, Chan KK, Brookes PA, de Kort H, McLean AG, Taube D, Cook HT. Roufosse CA, et al. Transplantation. 2012 Aug 15;94(3):269-74. doi: 10.1097/TP.0b013e31825774ab. Transplantation. 2012. PMID: 22790448

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters